Intellectual property rights of third parties
could limit our ability to market our products.
Our commercial
success also significantly depends on our ability to operate without infringing
the patents or violating the proprietary rights of others. The USPTO keeps U.S.
patent applications confidential while the applications are pending. As a
result, we cannot determine which inventions third parties claim in pending
patent applications that they have filed. We may need to engage in litigation
to defend or enforce our patent and license rights or to determine the scope
and validity of the proprietary rights of others. It will be expensive and time
consuming to defend and enforce patent claims. Thus, even in those instances in
which the outcome is favorable to us, the proceedings can result in the diversion
of substantial resources from our other activities. An adverse determination
may subject us to significant liabilities or require us to seek licenses that
third parties may not grant to us or may only grant at rates that diminish or
deplete the profitability of the products to us. An adverse determination could
also require us to alter our products or processes or cease altogether any
related research and development activities or product sales.
If we cannot meet requirements under our
license agreements, we could lost the rights to our products.
We depend, in
part, on licensing arrangements with third parties to maintain the intellectual
property rights to our products under development. These agreements may require
us to make payments and/or satisfy performance obligations in order to maintain
our rights under these licensing arrangements. All of these agreements last
either throughout the life of the patents, or with respect to other licensed
technology, for a number of years after the first commercial sale of the
relevant product.
In addition,
we are responsible for the cost of filing and prosecuting certain patent
applications and maintaining certain issued patents licensed to us. If we do
not meet our obligations under our license agreements in a timely manner, we
could lose the rights to our proprietary technology.
In addition,
we may be required to obtain licenses to patents or other proprietary rights of
third parties in connection with the development and use of our products and
technologies. Licenses required under any such patents or proprietary rights
might not be made available on terms acceptable to us, if at all.
We rely on confidentiality agreements that
could be breached and may be difficult to enforce.
Although we
believe that we take reasonable steps to protect our intellectual property,
including the use of agreements relating to the non-disclosure of confidential
information to third parties, as well as agreements that purport to require the
disclosure and assignment to us of the rights to the ideas, developments,
discoveries and inventions of our employees and consultants while we employ
them, the agreements can be difficult and costly to enforce. Although we seek
to obtain these types of agreements from our consultants, advisors and research
collaborators, to the extent that they apply or independently develop
intellectual property in connection with any of our projects, disputes may
arise as to the proprietary rights to this type of information. If a dispute
arises, a court may determine that the right belongs to a third party, and
enforcement of our rights can be costly and unpredictable. In addition, we will
rely on trade secrets and proprietary know-how that we will seek to protect in
part by confidentiality agreements with our employees, consultants, advisors or
others. Despite the protective measures we employ, we still face the risk that:
|
|
|
|
|
|
|
they will
breach these agreements; |
|
|
|
|
|
|
|
any
agreements we obtain will not provide adequate remedies for this type of
breach or that our trade secrets or proprietary know-how will otherwise
become known or competitors will independently develop similar technology;
and |
|
|
|
|
|
|
|
our
competitors will independently discover our proprietary information and trade
secrets. |
18